Healius Limited Strengthens Leadership with New Company Secretary Appointment

An update from Healius Limited ( (AU:HLS) ) is now available.

Healius Limited has announced the appointment of Kylie Brown as a Company Secretary, effective 29 May 2025. This strategic appointment, alongside the continued service of Stephen Humphries and Gillian Nairn in their respective roles, reinforces Healius’s commitment to maintaining robust communication and compliance with ASX Listing Rules, potentially enhancing its operational efficiency and stakeholder confidence.

The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.

More about Healius Limited

Healius Limited is one of Australia’s leading healthcare companies, dedicated to providing quality, affordable, and accessible healthcare services across the nation. With over 30 years of experience, Healius operates a wide network of centers and employs more than 8,500 staff, offering specialty pathology services to consumers and their referring practitioners.

Average Trading Volume: 3,161,629

Technical Sentiment Signal: Sell

Current Market Cap: A$642.6M

See more data about HLS stock on TipRanks’ Stock Analysis page.